|Title:||Pharmaceutical excipient having improved compressibility|
|Abstract:||A composition, comprising (a) microcrystalline cellulose; and (b) a compressibility augmenting agent which (i) physically restricts the proximity of the interface between adjacent cellulose surfaces; or (ii) inhibits interactions between adjacent cellulose surfaces; or (iii) accomplishes both (i) and (ii) above, is disclosed. The composition is in the form of agglomerated particles of microcrystalline cellulose and the compressibility augmenting agent in intimate association with each other.|
|Inventor(s):||Staniforth; John N. (Bath, GB2), Sherwood; Bob E. (Amenia, NY), Hunter; Edward A. (Glenham, NY)|
|Assignee:||Edward Mendell Co., Inc. (Patterson, NY)|
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form; Use;|
Field: Not categorized
Back Citations: 42nd percentile
Forward Citations: 6th percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.